These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction. Hall G; Heimdahl A; Nord CE Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):646-9. PubMed ID: 8894572 [TBL] [Abstract][Full Text] [Related]
6. A comparative study of cefaclor vs. amoxicillin/clavulanate in tonsillopharyngitis. Haczyński J; Bardadin J; Gryczyńska D; Gryczyński M; Gołabek W; Kawalski H; Kaźmierczak H; Krecicki T; Kubik P; Namysłowski G; Popiel L Med Sci Monit; 2001; 7(5):1016-22. PubMed ID: 11535952 [TBL] [Abstract][Full Text] [Related]
7. Serum sickness in a paediatric emergency department: the role of cefaclor. Parshuram CS; Phillips RJ; Nash MC J Paediatr Child Health; 1999 Apr; 35(2):223-4. PubMed ID: 10365368 [No Abstract] [Full Text] [Related]
8. [Comparison of azithromycin, amoxicillin/clavulanic acid and cefaclor in the treatment of acute ENT infections]. García Callejo FJ; Velert Vila MM; Orts Alborch MH; Pardo Mateu L; Esparcia Navarro M Acta Otorrinolaringol Esp; 1998 May; 49(4):306-12. PubMed ID: 9707742 [TBL] [Abstract][Full Text] [Related]
9. Cefaclor anaphylaxis in children. Novembre E; Mori F; Pucci N; Bernardini R; Romano A Allergy; 2009 Aug; 64(8):1233-5. PubMed ID: 19385950 [No Abstract] [Full Text] [Related]
10. Drug-induced hypersensivity syndrome associated with Epstein-Barr virus infection: a pediatric case report. Scagni P; Morello M; Ramus MV; Agostini M; Pagliero R Pediatr Dermatol; 2009; 26(2):229-31. PubMed ID: 19419485 [TBL] [Abstract][Full Text] [Related]
11. Long persistence of IgE antibody to cefaclor. Bernardini R; Novembre E; Lombardi E; Pucci N; Rossi ME; Vierucci A Allergy; 2000 Oct; 55(10):984-5. PubMed ID: 11030389 [No Abstract] [Full Text] [Related]
12. A case of drug eruption due to simultaneous sensitization with three different kinds of drugs. Nagayama H; Nakamura Y; Shinkai H J Dermatol; 1996 Dec; 23(12):899-901. PubMed ID: 9037924 [TBL] [Abstract][Full Text] [Related]
13. Serum sickness-like reaction to cefaclor: lack of in vitro cross-reactivity with loracarbef. Kearns GL; Wheeler JG; Rieder MJ; Reid J Clin Pharmacol Ther; 1998 Jun; 63(6):686-93. PubMed ID: 9663184 [TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. Tokura Y; Ishihara S; Tagawa S; Seo N; Ohshima K; Takigawa M J Am Acad Dermatol; 2001 Oct; 45(4):569-78. PubMed ID: 11568749 [TBL] [Abstract][Full Text] [Related]